03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
On August 5, 2020, Georgia Governor Brian Kemp signed a new law, Senate Bill 315, changing Georgia’...
Read More >
Employers who seek to sponsor foreign workers for cap-subject H-1B visas in 2020 will likely see a b...
Read More >
In a striking blow, stripping a city of a judgment of nearly $1 million, the Massachusetts Appeals C...
Read More >
The U. S. Department of the Treasury recently issued final regulations governing hardship distributi...
Read More >
What does Victoria’s Secret reveal about the perilous nature of doing deals in a pandemic? In two w...
Read More >
For many years, construction companies have been faced with the issue of whether they should treat a...
Read More >